In your stateSouth Dakota
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
Economic Impact In Your State: South Dakota
$180M
Total output supported by biophamaceutical sector
$247,776
Total output supported by biophamaceutical sector
986
Total Jobs
320
Direct Jobs
Clinical Trials in Your State: South Dakota
144
TOTAL CLINICAL TRIALS
$42.1 million
INVESTED IN CLINICAL TRIALS
2,338
TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS
$101.8 million
INVESTED IN CLINICAL TRIALS
Programs and Initiatives in Your State: South Dakota
State programs and initiatives to promote biopharmaceutical industry development
- ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT
BUILDING ADVANCED MANUFACTURING
BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE
STEM EDUCATION & WORKFORCE DEVELOPMENT
TARGETED STRATEGIES
VENTURE FINANCING